Silk Road Medical Inc Overview
Pro stress-test →Silk Road Medical is a medical device company located in Sunnyvale, California, focused on reducing stroke risk through TransCarotid Artery Revascularization (TCAR)—a minimally invasive procedure for treating carotid artery disease. The company was acquired by Boston Scientific Corporation in September 2024, making it a subsidiary of a major diversified medical device manufacturer.
Strategic Profile
Pro stress-test →TCAR combines surgical principles of neuroprotection with minimally invasive endovascular techniques to treat carotid artery blockages at stroke risk. The acquisition positions Silk Road's stroke-prevention technology within Boston Scientific's broader vascular portfolio, enabling accelerated market penetration and integration with complementary interventional solutions.
Competitive Landscape
Pro stress-test →Silk Road Medical competes in the minimally invasive stroke prevention and carotid artery intervention space against traditional surgical approaches and other interventional platforms. Primary competitors include established vascular device makers such as Medtronic, Abbott, and Stryker, as well as providers of carotid revascularization and neuroprotection devices. Boston Scientific's integration of Silk Road strengthens its competitive position in this specialized vascular market.
Industry Context
Silk Road Medical Inc operates in Medical Devices - Vascular Intervention.
Key facts
Founded: 2007 · Headquarters: Sunnyvale, US · Employees: 201-500 · Revenue: $177.13M